Beaubien G, Drolet P, Girard M, Grenier Y
Department of Anaesthesia, Maisonneuve-Rosemont Hospital and University of Montreal, Quebec, Canada.
Reg Anesth Pain Med. 2000 May-Jun;25(3):254-8. doi: 10.1016/s1098-7339(00)90007-5.
Combined spinal epidural anesthesia (CSEA) involves the epidural administration of local anesthetic and opioid solutions adjacent to the prior dural puncture, potentially increasing their diffusion into the subarachnoid space. This study was designed to evaluate the influence of dural puncture on the adequacy and extent of analgesia, and drugs requirements of patient-controlled epidural analgesia (PCEA) in the postoperative period.
In this prospective double-blind study, 40 patients undergoing major abdominal surgery under general anesthesia followed with PCEA were randomly assigned to either group I (preoperative insertion of an epidural catheter) or group II (preoperative dural puncture with a 25-g Quincke needle + insertion of an epidural catheter). Postoperatively, a PCEA pump delivered an infusion of 0.1% bupivacaine + fentanyl (3 microg/mL) at 5 mL/h. Participants were allowed to self-administer 5-mL boluses of the same solution with a 15-minute lock-out interval. Hourly epidural solution requirements were recorded for 40 hours. Sensory and motor block, and pain scores were also analyzed.
There was no difference between groups with regard to epidural solution requirements, pain scores, spread of sensory blockade, or intensity of motor block.
Dural puncture with a 25-gauge Quincke needle, performed as part of CSEA, does not influence the drug requirements when a combination of 0.1% bupivacaine and fentanyl (3 microg/mL) is used for PCEA after major abdominal surgery.
腰麻-硬膜外联合麻醉(CSEA)涉及在先前硬膜穿刺附近硬膜外给予局部麻醉药和阿片类溶液,这可能会增加它们向蛛网膜下腔的扩散。本研究旨在评估硬膜穿刺对术后患者自控硬膜外镇痛(PCEA)镇痛的充分性和范围以及药物需求的影响。
在这项前瞻性双盲研究中,40例接受全身麻醉后行PCEA的腹部大手术患者被随机分为I组(术前置入硬膜外导管)或II组(术前用25G Quincke针进行硬膜穿刺 + 置入硬膜外导管)。术后,PCEA泵以5 mL/h的速度输注0.1%布比卡因 + 芬太尼(3μg/mL)。参与者可自行给予5 mL相同溶液的推注量,锁定时间间隔为15分钟。记录40小时内每小时的硬膜外溶液需求量。还分析了感觉和运动阻滞以及疼痛评分。
两组在硬膜外溶液需求量、疼痛评分、感觉阻滞范围或运动阻滞强度方面无差异。
作为CSEA一部分进行的25G Quincke针硬膜穿刺,在腹部大手术后使用0.1%布比卡因和芬太尼(3μg/mL)联合用于PCEA时,不影响药物需求。